Premium
[O2–05–03]: CONCORDANCE BETWEEN CSF AD BIOMARKERS MEASURED BY THE AUTOMATED ELECSYS ASSAY AND IN VIVO AMYLOID IMAGING
Author(s) -
Fagan Anne M.,
Schindler Suzanne E.,
Gray Julia D.,
Gordon Brian A.,
Xiong Chengjie,
BatrlaUtermann Richard,
Quan Marian,
Wahl Simone,
Buckles Virginia D.,
Benzinger Tammie L.S.,
Morris John C.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - Hindi
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.07.169
Subject(s) - concordance , pittsburgh compound b , medicine , positron emission tomography , receiver operating characteristic , cerebrospinal fluid , nuclear medicine , dementia , pathology , standardized uptake value , amyloid (mycology) , disease
Mean Cortical SUVR amyloid PET CDR 0 1.16 (0.2) 1.21 (0.3) 0.70 CDR>0 1.67 (0.5) 1.72 (0.5) 0.97 CSF concentrations (pg/ml): Ab42 CDR 0 718.6 (301.2) 696.6 (294.3) 0.93 CDR>0 537.8 (318.1) 472.4 (231.9) 0.75 CSF concentrations (pg/ml):total tau CDR 0 214.0 (102.8) 304.0 (170.5) 0.01 CDR>0 393.3 (245.7) 553.5 (342.0) 0.01 CSF concentrations (pg/ml): p-tau CDR 0 44.8 (19.4) 57.0 (26.6) 0.02 CDR>0 68.0 (35.4) 85.2 (45.0) 0.09 Podium Presentations: Monday, July 17, 2017 P561